Current Drug Targets - Cardiovascular & Hematological Disorders

Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression
pp. 431-432(2)
Authors: Schoenhagen, Paul; Nissen, Steven E.

Animal Models of Atherosclerosis Progression: Current Concepts
pp. 433-440(8)
Authors: McMahon, A. C.; Kritharides, L.; Lowe, H. C.

HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
pp. 441-453(13)
Authors: Kleemann, R.; Kooistra, T.

Cholesterol Absorption Blockade with Ezetimibe
pp. 455-462(8)
Authors: Toth, Peter P.; Davidson, Michael H.

Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase
pp. 463-469(7)
Authors: Miyazaki, Akira; Kanome, Tomoko; Watanabe, Takuya

ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression
pp. 471-479(9)
Authors: Kaul, Sanjay; Shah, Prediman K.

Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?
pp. 481-488(8)
Authors: Van der Steeg, W. A.; El-Harchaoui, K.; Kuivenhoven, J. A.; Kastelein, J. J.P.

A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence
pp. 489-501(13)
Author: Mason, R. P.

Preventing Atherosclerosis with Angiotensin-Converting Enzyme Inhibitors: Emphasis on Diabetic Atherosclerosis
pp. 503-512(10)
Authors: Allen, T. J.; Jandeleit-Dahm, K. A.

Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis
pp. 513-525(13)
Authors: Gouni-Berthold, I.; Krone, W.

Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis
pp. 527-532(6)
Authors: Zalewski, A.; Macphee, C.; Nelson, J. J.

Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases
pp. 533-540(8)
Authors: Bruemmer, Dennis; Law, Ronald E.

Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis
pp. 541-548(8)
Author: Rouis, Mustapha

Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction
pp. 549-556(8)
Author: Gadde, Kishore M.

Non-invasive Atherosclerosis Imaging: Use to Assess Response to Novel or Combination Lipid Therapies
pp. 557-564(8)
Authors: Villines, Todd C.; Taylor, Allen J.